Although mid-sized pharmaceutical companies have fallen behind in sales, but not in R&D
While research and development(R&D) of pharmaceutical companies have been accelerated, it is known that the ranking for R&D expenses against sales and their increase rates has been changed a number of times. It is analyzed, particularly, that mid-sized pharmaceutical companies have actively inves...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
